Etiometry Expands its Clinical Decision-Support Software with a NICU Focus
News and Press Releases
BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today.
Advancements in monitoring and support technologies have aided clinicians in improving the care they deliver and the impact they have had in improving the health and outcomes of NICU patients. Etiometry is focused on delivering technologies to further aid NICU clinicians in identifying and managing patients at risk of hemodynamic and respiratory instability to avoid complications and speed recovery.
WATCH THIS: Etiometry Supporting NICU Initiatives
“These are arguably the most delicate patients to treat and we do not take that responsibility lightly. The Etiometry Platform provides clinicians with easy access and visibility to available patient data when and where it is needed for critical decision support, as well as determining the progress of the patient’s condition,” explained Etiometry’s CEO, Shane Cooke.
The Etiometry Platform harnesses patient data to create novel risk indices for clinicians to better identify trending stages of clinical deterioration to improve the quality of care and health of individual patients. Etiometry is the first company to earn FDA-clearance for two critical care risk indices for patients under 12 years old.
NICU Awareness Month was created to celebrate the clinicians who take care of the tiniest patients and the families who never leave their side during a difficult journey. To support NICU Awareness Month, please join Etiometry in wearing green and using the hashtag #NICUAwarenessMonth.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com
Related
Why Measuring Key Clinical Markers Matters in Cardiogenic Shock
Cardiogenic shock (CS) remains a critical issue in hospitals nationwide. Despite advances in interventional cardiology, CS is a high-mortality condition, with mortality ranges from 30% to 40%, and 1-year mortality approaches or exceeds 50%. One of the main challenges is the rapid progression of CS severity. Historically, staging using the Society for Cardiovascular Angiography and […]
Why Conventional EHR Systems Are Insufficient for Shock Detection
Cardiogenic shock (CS) remains a critical and life-threatening condition, characterized by a rapid decline in cardiac function and multi-organ dysfunction, often leading to high mortality rates. Despite advancements in critical care, its intricate and rapidly evolving nature presents a formidable clinical challenge. Early identification and prompt intervention are paramount for improved patient outcomes. However, the […]
Three Practical Steps to Improve Institutional Readiness for Cardiogenic Shock
Cardiogenic shock (CS) represents a profound and often fatal complication in hospitalized patients, with short-term mortality rates persisting at a concerning 40% to 50%. Despite significant advancements in cardiovascular critical care and interventional cardiology, its intricate and rapidly evolving nature continues to present a formidable clinical challenge. Crucially, the initial manifestations of CS are frequently […]